Wai Chun Bio-Technology Ltd. (0660) Ratios
Wai Chun Bio-Technology Ltd. Ratios
HK:0660's free cash flow for Q4 2025 was $22.41M. For the 2025 fiscal year, HK:0660's free cash flow was increased by $0.00 and operating cash flow was $22.41M. See a summary of the company’s cash flow.
| Ratios | Jun 24 | Jun 23 | Jun 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.39 | ― | 0.81 | 0.86 | 0.60 |
| Quick Ratio | 0.18 | ― | 0.58 | 0.33 | 0.25 |
| Cash Ratio | 0.02 | ― | 0.04 | 0.04 | 0.04 |
| Solvency Ratio | -0.01 | ― | -0.01 | -0.01 | 0.04 |
| Operating Cash Flow Ratio | -0.00 | ― | 0.29 | 0.00 | -0.00 |
| Short-Term Operating Cash Flow Coverage | -0.01 | ― | 0.72 | 0.00 | -0.01 |
| Net Current Asset Value | $ -170.54M | ― | $ -100.52M | $ -91.14M | $ -111.04M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.44 | ― | 0.56 | 0.61 | 0.69 |
| Debt-to-Equity Ratio | -1.05 | ― | -3.84 | -4.01 | -3.46 |
| Debt-to-Capital Ratio | 23.15 | ― | 1.35 | 1.33 | 1.41 |
| Long-Term Debt-to-Capital Ratio | 0.00 | ― | 1.98 | 2.35 | 3.71 |
| Financial Leverage Ratio | -2.36 | ― | -6.86 | -6.63 | -5.02 |
| Debt Service Coverage Ratio | 0.15 | ― | 0.13 | 0.28 | 0.20 |
| Interest Coverage Ratio | 0.39 | ― | 0.87 | 1.49 | 1.41 |
| Debt to Market Cap | 3.98 | ― | 7.80 | 2.26 | 0.97 |
| Interest Debt Per Share | 0.63 | ― | 0.90 | 0.99 | 0.83 |
| Net Debt to EBITDA | 4.95 | ― | 8.60 | 4.55 | 7.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 9.55% | ― | 6.52% | 8.95% | 8.62% |
| EBIT Margin | 1.25% | ― | 0.00% | 3.10% | 1.96% |
| EBITDA Margin | 4.75% | ― | 1.93% | 4.71% | 3.09% |
| Operating Profit Margin | 1.42% | ― | 1.93% | 3.10% | 1.96% |
| Pretax Profit Margin | -2.37% | ― | -0.74% | 0.38% | 0.28% |
| Net Profit Margin | -3.88% | ― | -1.99% | -2.14% | 0.18% |
| Continuous Operations Profit Margin | -2.84% | ― | 0.00% | 0.00% | 0.18% |
| Net Income Per EBT | 163.73% | ― | 270.85% | -570.43% | 61.76% |
| EBT Per EBIT | -166.75% | ― | -38.26% | 12.10% | 14.45% |
| Return on Assets (ROA) | -6.81% | ― | -6.42% | -5.75% | 0.53% |
| Return on Equity (ROE) | 16.06% | ― | 44.09% | 38.07% | -2.65% |
| Return on Capital Employed (ROCE) | -8.55% | ― | 18.30% | 29.03% | 29.08% |
| Return on Invested Capital (ROIC) | 16.46% | ― | 10.28% | -4.87% | 5.89% |
| Return on Tangible Assets | -6.81% | ― | -6.42% | -5.75% | 0.63% |
| Earnings Yield | -61.09% | ― | -89.57% | -21.42% | 0.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.98 | ― | 18.25 | 13.24 | 40.40 |
| Payables Turnover | 4.45 | ― | 11.31 | 13.77 | 12.01 |
| Inventory Turnover | 6.04 | ― | 19.25 | 6.52 | 9.92 |
| Fixed Asset Turnover | 4.05 | ― | 6.97 | 6.91 | 8.36 |
| Asset Turnover | 1.76 | ― | 3.22 | 2.69 | 3.01 |
| Working Capital Turnover Ratio | -2.43 | ― | -28.06 | -15.76 | -8.63 |
| Cash Conversion Cycle | 8.92 | ― | 6.69 | 57.00 | 15.44 |
| Days of Sales Outstanding | 30.46 | ― | 19.99 | 27.56 | 9.04 |
| Days of Inventory Outstanding | 60.48 | ― | 18.96 | 55.94 | 36.80 |
| Days of Payables Outstanding | 82.02 | ― | 32.27 | 26.50 | 30.40 |
| Operating Cycle | 90.94 | ― | 38.96 | 83.51 | 45.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | ― | 0.27 | 0.00 | -0.00 |
| Free Cash Flow Per Share | -0.16 | ― | 0.10 | -0.10 | -0.08 |
| Dividend Paid and CapEx Coverage Ratio | -0.04 | ― | 1.61 | 0.02 | -0.03 |
| Capital Expenditure Coverage Ratio | -0.04 | ― | 1.61 | 0.02 | -0.03 |
| Operating Cash Flow Coverage Ratio | -0.01 | ― | 0.34 | 0.00 | -0.00 |
| Operating Cash Flow to Sales Ratio | -0.00 | ― | 0.06 | 0.00 | -0.00 |
| Free Cash Flow Yield | -112.92% | ― | 100.03% | -24.46% | -9.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.64 | ― | -1.12 | -4.67 | 135.06 |
| Price-to-Sales (P/S) Ratio | 0.06 | ― | 0.02 | 0.10 | 0.24 |
| Price-to-Book (P/B) Ratio | -0.26 | ― | -0.49 | -1.78 | -3.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.89 | ― | 1.00 | -4.09 | -10.37 |
| Price-to-Operating Cash Flow Ratio | -23.56 | ― | 0.38 | 171.92 | -325.39 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | ― | -0.17 | 0.00 | -1.52 |
| Enterprise Value Multiple | 6.29 | ― | 9.75 | 6.67 | 14.77 |
| Enterprise Value | 112.57M | ― | 145.25M | 210.81M | 258.72M |
| EV to EBITDA | 6.29 | ― | 9.75 | 6.67 | 14.77 |
| EV to Sales | 0.30 | ― | 0.19 | 0.31 | 0.46 |
| EV to Free Cash Flow | -4.16 | ― | 8.43 | -12.86 | -19.96 |
| EV to Operating Cash Flow | -110.80 | ― | 3.20 | 540.54 | -626.44 |
| Tangible Book Value Per Share | -0.36 | ― | 0.06 | 0.04 | -0.26 |
| Shareholders’ Equity Per Share | -0.53 | ― | -0.21 | -0.23 | -0.23 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.20 | ― | -0.77 | 1.37 | 0.38 |
| Revenue Per Share | 2.17 | ― | 4.58 | 4.01 | 3.42 |
| Net Income Per Share | -0.08 | ― | -0.09 | -0.09 | 0.01 |
| Tax Burden | 1.64 | ― | 2.71 | -5.70 | 0.62 |
| Interest Burden | -1.89 | ― | 0.00 | 0.12 | 0.14 |
| Research & Development to Revenue | 0.01 | ― | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.09 | ― | 0.03 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | ― | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.07 | ― | -2.94 | -0.03 | -0.26 |
Currency in HKD